Equities

Alphatec Holdings Inc

Alphatec Holdings Inc

Actions
  • Price (USD)10.68
  • Today's Change-0.35 / -3.17%
  • Shares traded1.06m
  • 1 Year change-29.57%
  • Beta1.4246
Data delayed at least 15 minutes, as of May 21 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. The Company is focused on the design, development, and advancement of technology for surgical treatment of spine disorders. It has a range of product portfolios designed to address the spine's various pathologies. Its AIX product platform comprises of its EOS imaging system and VEA alignment mobile application, its SafeOp Neural InformatiX System and Valence. The EOS imaging system is designed to provide calibrated full-body imaging that enables a three-dimensional (3D) model of patients’ skeletal systems. It has developed a patient positioning systems that integrates with its other access systems, providing for a more rigid construct and enhanced reproducibility. It offers procedure-specific access systems, including its Sigma-ALIF Access System, which allows for custom anterior abdominal exposure.

  • Revenue in USD (TTM)511.63m
  • Net income in USD-191.60m
  • Incorporated2005
  • Employees839.00
  • Location
    Alphatec Holdings Inc5818 El Camino RealCARLSBAD 92008United StatesUSA
  • Phone+1 (760) 431-9286
  • Fax+1 (302) 636-5454
  • Websitehttps://atecspine.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Artivion Inc368.21m-9.58m993.70m1.50k--3.3772.932.70-0.2615-0.26158.647.070.47791.645.37245,470.70-1.25-2.20-1.33-2.3664.7565.51-2.61-5.344.262.260.5176--12.826.14-60.09--5.13--
BioLife Solutions Inc137.30m-62.93m1.00bn409.00--2.99--7.32-1.43-1.433.107.300.32382.175.61335,687.00-14.84-13.76-16.52-15.0432.9736.76-45.84-42.991.77-32.080.0717---11.4348.6552.49--86.35--
AtriCure Inc414.60m-37.23m1.08bn1.20k--2.37--2.60-0.8005-0.80058.929.430.70591.708.21345,501.70-6.34-3.72-7.08-4.1075.2674.36-8.98-7.642.83-10.270.1212--20.8414.6434.49--46.56--
Coretag Inc0.00-34.52k1.13bn0.00---------0.3806-0.38060.00-0.98010.00-------3,303.35--------------------------10.95------
MiMedx Group Inc334.51m71.52m1.18bn895.0021.237.5814.823.530.37670.33932.151.061.722.826.58373,754.2041.80-4.1453.13-5.9083.5083.6124.36-2.702.719.000.111--20.03-2.19310.29---26.47--
Adapthealth Corp3.25bn-695.41m1.32bn10.70k--0.9012--0.4056-5.18-5.1824.2710.970.663721.668.30303,555.90-14.15-4.34-15.82-4.8918.4518.28-21.32-6.471.112.080.6025--7.73---1,169.99------
Owens & Minor, Inc.10.42bn-38.77m1.38bn13.70k--1.545.470.1321-0.5099-0.5099136.9811.711.986.7914.60760,861.20-0.73721.32-1.112.0720.7516.48-0.37190.56140.56482.190.70650.7983.801.87-284.47--25.91--
Establishment Labs Holdings Inc155.79m-82.76m1.49bn781.00--26.07--9.54-3.15-3.155.912.070.60950.91913.39171,579.30-32.38-33.22-39.25-41.1265.0164.73-53.12-43.192.73-21.300.7715--2.1321.96-4.38--69.16--
Alphatec Holdings Inc511.63m-191.60m1.54bn839.00--41.83--3.02-1.49-1.493.970.42940.76121.346.70609,808.10-28.51-30.97-37.13-39.4765.8966.02-37.45-46.221.49-5.170.8938--37.4539.38-23.36--67.92--
Inmode Ltd466.26m181.11m1.61bn581.009.021.938.853.452.112.115.429.870.59731.7116.09802,509.4023.2031.3225.2135.6483.1084.4638.8439.6512.66--0.000.008.3237.4922.5454.6513.10--
LeMaitre Vascular Inc199.89m33.95m1.78bn614.0052.605.7840.978.921.511.518.8913.740.59771.177.19325,548.9010.159.0210.999.9366.4565.8316.9915.455.31--0.0040.4119.6912.8845.895.9618.9315.51
UFP Technologies Inc407.33m47.88m1.98bn3.09k41.576.7133.274.866.216.2152.8238.461.024.506.71131,693.2011.999.6913.8010.9527.8926.3311.7510.141.4617.870.10390.0013.0816.007.5025.7114.08--
Warby Parker Inc697.80m-55.06m1.98bn2.14k--6.27--2.84-0.467-0.4675.912.661.215.19655.52326,074.80-9.57---11.95--55.0157.49-7.89-14.532.02--0.00--11.9819.6742.75------
Premier Inc1.34bn80.33m2.05bn2.80k30.431.0610.411.530.64210.642111.3418.350.38875.253.10477,306.101.8910.392.4813.0066.2062.044.8722.600.8226143.620.27619.11-6.762.44-34.17-15.30-2.29--
STAAR Surgical Co326.24m15.30m2.10bn1.06k138.365.35101.606.450.30930.30936.628.000.71592.115.09308,942.303.366.773.827.9078.5176.894.699.165.22--0.00040.0013.3721.07-46.1833.8551.95--
Data as of May 21 2024. Currency figures normalised to Alphatec Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

28.77%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Mar 20246.76m4.90%
First Light Asset Management LLCas of 31 Mar 20245.42m3.93%
The Vanguard Group, Inc.as of 31 Mar 20245.27m3.82%
Millennium Management LLCas of 31 Mar 20245.16m3.74%
American Century Investment Management, Inc.as of 31 Mar 20244.17m3.02%
JPMorgan Investment Management, Inc.as of 31 Mar 20242.77m2.01%
Driehaus Capital Management LLCas of 31 Mar 20242.64m1.91%
Fred Alger Management LLCas of 31 Mar 20242.62m1.90%
Alyeska Investment Group LPas of 31 Mar 20242.53m1.83%
SSgA Funds Management, Inc.as of 31 Mar 20242.37m1.72%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.